Navigation Links
New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace

First comprehensive study of market dynamics offers insights into what will be needed to get new, faster and better TB drugs to patients

NEW YORK, May 14, 2007 /PRNewswire-USNewsire/ -- The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of new TB drugs, today released results from the first comprehensive study of the dynamics of the global TB drug market that offers a detailed analysis of how today's TB medicines reach patients around the world, and an estimate of the value of the global market for first-line TB treatments.

The study, Pathway to Patients: Charting the Dynamics of the Global TB Drug Market, reveals the variability and complexities faced at all levels of the TB drug supply chain; the highly fragmented nature of the global marketplace in terms of purchase, supply and delivery; the important role of local and national governments in procurement and distribution; and the limited commercial market potential for new TB drugs.

"The absence of a viable commercial market has clearly held back TB drug research for decades," said Maria C. Freire, CEO and President of the TB Alliance. "This groundbreaking study reaffirms the mission of the TB Alliance to develop new, faster and better TB drugs, and the importance of working to ensure these lifesaving new cures reach all those who need them."

Pathway to Patients studied the TB drug market in ten strategically selected countries, including high burden, emerging and high income markets (Brazil, China, France, India, Indonesia, Japan, the Philippines, South Africa, the United Kingdom and the United States) to obtain country specific market data and provide a comprehensive understanding in eight key countries of procurement and distribution systems.

The study projects an estimate of the global market for first-line TB drugs of approxim
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:6/2/2015)...  Accuray Incorporated (Nasdaq: ARAY ), announced today ... the Goldman Sachs 36th Annual Global Healthcare Conference in ... Wednesday, June 10, 2015 at 4:00pm PT.   ... available on the Investor Relations page of the Company,s ... the presentation will begin approximately one hour after the ...
(Date:6/2/2015)... , Minn. and WELLESLEY, Mass., June 2, 2015 ... owner, Ampersand Capital Partners (Ampersand), announced the acquisition ... of Array BioPharma Inc. (Array).  Accuratus was formed ... Eagan, MN acquired Microtest Labs ... analytical and microbial testing services to the medical ...
(Date:6/2/2015)...  Nektar Therapeutics (NASDAQ: NKTR ) and The ... a research collaboration that includes a Phase 1/2 clinical ... preferentially stimulate production of CD8-positive T cells, which are ... which is also known as the Interleukin-2 receptor beta ... to increase proliferation of these effector T cells. 1 ...
Breaking Medicine Technology:Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 2Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 3Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 4Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 5Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 6
... Pharmasset, Inc. (Nasdaq: VRUS ) announces that ... to be held September 20-22, 2010 at the Grand Hyatt, ... Officer, will provide an overview of the company at the ... (ET). To access a simultaneous webcast of Mr. ...
... (NYSE: ALR ) announced today that, in connection ... due 2018, it entered into a purchase agreement with the ... size of the offering was increased from $350.0 million to ... are being offered at 100.0% of the aggregate principal amount ...
Cached Medicine Technology:Pharmasset to Present at the UBS Global Life Sciences Conference 2Pharmasset to Present at the UBS Global Life Sciences Conference 3Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million 2
(Date:6/2/2015)... (PRWEB) June 02, 2015 Milton Hershey ... one of the 30 members of the Physician Assistant ... of Medicine. He was presented with a white coat, ... , “We are extremely proud of Vincent’s accomplishments both ... “He is a great example of how a top-notch ...
(Date:6/2/2015)... 2015 Erbelli’s Gourmet Pizzeria, Italian Bistro ... its handmade gourmet pizzas and calzones, fresh wraps, submarine ... is new, the recipes are not—they have been satisfying ... feature of the site is the menu, which is ... of all the items. You can order directly from ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 IMPAK ... sorbent systems, has announced the availability of “child-resistant” ... of poisons by children, especially curious toddlers. The ... standards and tested to CFR 1700.20 protocols. The ... Cullen. , Looks Like Candy, “With the proliferation ...
(Date:6/2/2015)... Acara Partners has seen a spike in ... mobile devices, as is now required by recent Google search ... well as several new clients in the medical aesthetics vertical, ... them to meet Google’s new requirements,” commented Fran Acunzo, CEO ... clients in education, non-profits, and the business world.” , ...
(Date:6/2/2015)... DiaTech Oncology, provider of CorrectChemo®, ... to help oncologists provide personalized cancer treatment, has ... (CAP) for its laboratories in the U.S. and ... to the ‘Good Housekeeping’ seal of approval,” says ... for DiaTech. “It’s a rigorous inspection that confirms ...
Breaking Medicine News(10 mins):Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Acara Partners Expands Website and Digital Offerings 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2
... Organization Los Angeles, (EO-LA) May Chapter event tonight, CVS ... along the way from CVS,s inception to the retail ... the Andaz West Hollywood Hotel, located at 8401 Sunset ... Mr. Hoagland will take place in the rooftop Panorama ...
... 12 The "Benzene Litigation Conference" will take ... panel of highly experienced attorneys and health experts. ... Metzger Law Group in Long Beach, Calif., and ... Dallas."This is a state-of-the-art benzene litigation conference," said ...
... draws from personal experience with American private care ... provincesMIAMI , May 12 ... a Democratic constituent in her Florida district are ... in America in a personal letter to every ...
... that posed by other strains of influenza, CDC says , , ... Tuesday that they,re seeing some complications among pregnant women as ... "Pregnant women are at higher risk of complications of influenza, ... We are also seeing some severe complications in women with ...
... people have many strategies for building bigger muscles and stronger ... brain? , Meditate. , ... who used high-resolution magnetic resonance imaging (MRI) to scan the ... the journal NeuroImage and currently available online (by ...
... May 12 The YWCA USA Annual General Assembly elected new ... National Coordinating Board, during its recent 2009 National Conference in Washington, ... Chair: Debra Stock, Executive Director of YWCA ... Jeanette Castellanos-Butt, Associate Director of YWCA Greater Chicago, Illinois , ...
Cached Medicine News:Health News:Benzene Litigation Conference July 24 2Health News:Florida Congresswoman Sends to Every Member of Senate Canadian-born U.S. Citizen's Prescription for Health Care Reform 2Health News:Swine Flu May Pose Problems for Pregnant Women 2Health News:Swine Flu May Pose Problems for Pregnant Women 3Health News:Swine Flu May Pose Problems for Pregnant Women 4Health News:Swine Flu May Pose Problems for Pregnant Women 5Health News:Swine Flu May Pose Problems for Pregnant Women 6Health News:Swine Flu May Pose Problems for Pregnant Women 7Health News:Swine Flu May Pose Problems for Pregnant Women 8Health News:Swine Flu May Pose Problems for Pregnant Women 9Health News:How to build a bigger brain 2Health News:YWCA USA Elects New National Leadership 2
Weight adjuster flexible back, comfortably places more weight on hips, less weight on shoulders....
All Purpose, General Procedure Apron...
Designed for special procedures, this Wrap-Around apron has .50mm Pb in the front and .25mm Pb in the back. The velcro fasteners are adjustable to provide the most comfortable fit....
Designed to fit the body and priced to fit the budget! The Economy Tie apron has a belt that wraps around the body and ties in the front. Don't let the price fool you.... this apron provides the same...
Medicine Products: